Development and validation of high-performance liquid chromatographic method for estimation of lercanidipine in rabbit serum

Analytical Letters

Volumn 40, Issue 11, 2007, Pages 2128-2140

  Charde, Shrikant ^a   Kumar, Lajwinder ^a   Saha, Ranendra ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

1,4 dihydropyridine; High performance liquid chromatography; Lercanidipine hydrochloride; Rabbit serum

Indexed keywords

ORYCTOLAGUS CUNICULUS;

EID: 36248989564     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710701566636     Document Type: Article

References (18)

1. Alvarez-Lueje, A., Pujol, S., Nunez-Vergara, L.J., and Squella, J.A. 2002. Differential pulse voltammetric assay of lercanidipine in tablets. J. AOAC Int., 85: 1247-1252.
2. Alvarez-Lueje, A., Pujol, S., Squella, J.A., and Nunez-Vergara, L.J. 2003. A selective HPLC method for determination of lercanidipine in tablets. J. Pharm. Biomed. Anal., 31: 1-9.
3. Bang, L.M., Chapman, T.M., and Goa, K.L. 2003. Lercanidipine a review of its efficacy in the management of hypertension. Drugs, 63: 2449-2472.
4. Baranda, A.B., Etxebarria, N., Jimenez, R.M., and Alonso, R.M. 2005a. Improvement of the chromatographic separation of several 1,4-dihydropyridine calcium channel antagonist drugs by experimental design. J. Chromatogr. Sci., 43: 505-512.
5. Baranda, A.B., Jimenez, R.M., and Alonso, R.M. 2004. Simultaneous determination of five 1,4-dihydropyridines in pharmaceutical formulations by high-performance liquid chromatography-amperometric detection. J. Chromatogr. A, 1031: 275-280.
6. Baranda, A.B., Mueller, C.A., Alonso, R.M., Jimenez, R.M., and Weinmann, W. 2005b. Quantitative determination of the calcium channel antagonists amlodipine, lercanidipine, nitrendipine, felodipine, and lacidipine in human plasma using liquid chromatography-tandem mass spectrometry. Ther. Drug Monit., 27: 44-52.
7. Barchielli, M., Dolfini, E., Farina, P., Leoni, B., Targa, G., Vinaccia, V., and Tajana, A. 1997. Clinical pharmacokinetics of lercanidipine. J. Cardiovasc. Pharmacol., 29: S1-S15.
8. Bolton, S. 1997. Pharmaceutical Statistics: Practical and Clinical Applications, 3rd edn.; Marcel Dekker: New York.
9. Christians, T., Diewald, D., Wessler, C., Otte, Y., Lehmann, J., and Holzgrabe, U. 1999. Resolution of newly synthesized racemic dihydropyridines with different chiral selectors by means of capillary electrophoresis. J. Chromatogr. A, 853: 455-460.
10. Erk, N. 2003. Extractive spectrophotometric methods for determination of lercanidipine. Pharmazie, 58: 801-803.
11. Fiori, J., Gotti, R., Bertucci, C., and Cavrini, V. 2006. Investigation on the photochemical stability of lercanidipine and its determination in tablets by HPLC-UV and LC-ESI-MS/MS. J. Pharm. Biomed. Anal., 41: 176-181.
12. International Conference on Harmonisation (ICH), 1996. Harmonized tripartite guideline on, Topic Q2B, Notes for Guidelines for Validation of Analytical Procedures: Methodology; Pub. by The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit.
13. Jabor, V.A., Coelho, E.B., Ifa, D.R., Bonato, P.S., Dos-Santos, N.A., and Lanchote, V.L. 2003. Enantioselective determination of lercanidipine in human plasma for pharmacokinetic studies by normal-phase liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 796: 429-437.
14. Kalovidouris, M., Michalea, S., Robola, N., Koutosopoulou, M., and Panderi, I. 2006. Ultra-performance liquid chromatography/tandem mass spectroscopy method for determination of lercanidipine in human plasma. Rapid Commun. Mass Spectrom., 20: 2939-2946.
15. Lüscher, T.F. and Cosentino, F. 1998. The classification of calcium antagonists and their selection in the treatment of hypertension: a reappraisal. Drugs, 55: 509-517.
16. McClellan, K.J. and Jarvis, B. 2000. Lercanidipine a review of its use in hypertension. Drugs, 60: 1123-1140.
17. Salem, I.I., Idress, J., Al-Tamimi, J.I., and Farina, P. 2004. Selective and rapid liquid chromatography-mass spectrometry method for the determination of lercanidipine in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 803: 201-207.
18. United States Pharmacopoeia (USP), XXVI, 2003. Validation of compendial methods, 26th edn.; Rockville, MD: United States Pharmacopoeial Convention Inc, p. 2439-2442.